How to Avoid Desk Rejection at Nature Chemical Biology

Nature Chemical Biology editors are asking one question before they read the methods or results: does this paper need both chemistry and biology to tell its story?

That question has several components:

This is the single most important criterion. The journal wants work where a chemical approach, whether a probe, an inhibitor, a synthetic molecule, or a metabolite, makes a biological discovery possible that would not have been accessible through genetics, biochemistry, or other standard biological tools.

A new fluorescent sensor that is brighter or more selective than existing ones is a chemistry advance. A new fluorescent sensor that reveals a previously unknown signaling process in living cells is a chemistry-biology advance. The distinction is in what the tool reveals, not how well it works.

Editors can identify papers where the biology was added to justify submission to this journal rather than a chemistry journal. The tell is usually in the experimental flow: if the paper would still be interesting to the authors' chemistry colleagues with the biological data removed, the biology is decorative.

Genuinely interdisciplinary papers have a different structure. The biological question motivates the chemical design, and the chemical design is shaped by biological constraints. The experiments alternate between chemical and biological reasoning in a way that makes the two inseparable.

Nature Chemical Biology expects mechanistic depth. A paper that shows a compound has a biological effect without explaining why the effect occurs at a molecular level is usually premature for this journal.

This does not mean every paper needs a crystal structure or a complete mechanistic pathway. But preliminary mechanistic insights, evidence that rules out alternative explanations, and a clear framework for understanding the observed biology at a molecular level are expected.

The manuscript needs to be accessible to chemists who think biologically and biologists who think chemically. An introduction that spends three paragraphs on biological context and one sentence on the chemical approach signals a biology paper dressed in chemical biology language. The reverse signals a chemistry paper with biological window dressing.

Both fields need enough context in the introduction that readers from either discipline can follow the reasoning, understand why the question matters, and appreciate the approach.

This is the most frequent desk rejection trigger. The core contribution is a new compound, probe, sensor, or synthetic method. The biological data (cell viability assays, imaging experiments, animal studies) are included to demonstrate that the chemistry "works" in a biological context.

The problem: the biological experiments validate the chemical advance but do not generate new biological insight. If the paper would be equally interesting in JACS, Angewandte Chemie, or ACS Chemical Biology without the biological data, it belongs at a chemistry journal.

The reverse mismatch. The discovery is a biological finding (a new pathway, a new mechanism, a new cellular process), and chemical tools were used to make the discovery. But the chemical tools are commercially available or previously published, and the chemical thinking is not what drove the experimental design.

The paper is really a biology paper that happens to use chemistry as a tool. It would be better served by a biology journal like Nature Cell Biology, Molecular Cell, or a disease-specific journal.

A better fluorescent sensor, a more selective inhibitor, or a more efficient synthesis of a known compound type. These represent real chemistry advances, but Nature Chemical Biology asks: what can researchers do with this tool that they could not do before at all? If the answer is "the same thing, but better," the paper does not meet the journal's novelty standard.

A paper showing that compound X kills cancer cells, modifies gene expression, or alters animal behavior. Without understanding why at a molecular level (target identification, pathway analysis, evidence ruling out off-target effects), the work is phenomenological. Nature Chemical Biology expects mechanistic depth that goes beyond observing an effect.

Papers where the chemistry is excellent but the biological experiments lack proper controls, or where the biology is strong but the chemical characterization is incomplete. Nature Chemical Biology holds both disciplines to full rigor standards. Reviewers include experts from both fields and will identify gaps in either.

For chemistry: compounds need full characterization (NMR, mass spectrometry, purity data). Probes need selectivity profiling. Inhibitors need dose-response curves and off-target controls. For biology: experiments need negative controls, biological replicates (not just technical replicates), appropriate statistical tests, and orthogonal validation of key findings. A paper that is strong in one domain but weak in the other signals that the interdisciplinary collaboration was superficial.

Editors read the cover letter before the paper. A cover letter that describes the findings without explaining why they require both chemistry and biology to appreciate misses the chance to frame the paper correctly. The cover letter should explicitly state what biological question could only be answered through the chemical approach described, and why the resulting insight matters to both communities. Generic statements about "interdisciplinary significance" without specifics do not help.

The abstract and introduction should answer three questions within the first 300 words:

• what biological question could not be answered without a chemical approach?
• what did the chemical approach reveal about the biology?
• why does the discovery matter to both chemists and biologists?

The manuscripts that miss here usually are not bad chemistry papers or bad biology papers. They are papers where one side is doing most of the real work and the other side is present mainly to create journal fit. We often see elegant probes without enough new biology, or interesting biology that still does not genuinely require chemical thinking to explain.

The other repeat problem is interface clarity. Editors need to see very quickly that the chemistry is enabling the biology and that the biology is giving the chemistry a reason to exist. If that two-way dependency is not obvious early, the paper starts looking better suited to a chemistry or biology journal with a narrower lane.

If these answers are clear, the paper has passed the most important editorial test before the methods or results are even evaluated.

• Is Nature Chemical Biology a Good Journal?
• Nature Chemical Biology Submission Guide
• Nature Chemical Biology Submission Process

A Nature Chemical Biology submission readiness check takes about 1-2 minutes.